SymNexus Ltd. — Software
AI software for cell image analysis and pharmaceutical compliance.
We build two products: FluorocellAI, which automates cell counting and analysis for research labs, and ComplianceCall, which tracks pharmaceutical development against federal regulation in real time.
FluorocellAI — segmentation view →
Live Regulatory Benchmark
FDA — synced- Current
Hazard classification — Compound A-114
Synced today
- Changed
Hazard classification — Compound B-207
Updated 2 days ago
- Current
Federal filing checklist
Synced today
- Current
Document control log
Synced today
ComplianceCall — regulatory dashboard →
Illustrative interface previews. Request a demonstration to see the live product.
3–4 days → same-day
FluorocellAI turnaround
Manual review compressed to a same-day first pass
2
Products in production
FluorocellAI and ComplianceCall
5+ yrs
Experience per engineer
Building custom-deployed AI for clients
What We Sell
Two products. Two regulated workflows.
FluorocellAI
Upload your microscopy images. Get automated cell counts, segmentation, and a QC audit trail back the same day — instead of a week of manual review.
ComplianceCall
A live dashboard that benchmarks your pharmaceutical development against current federal regulation, with full history and audit trail built in.
From Pilot Customers
What our early customers say.
“A cancer-research lab's cell-analysis workflow that took three to four days of manual review now compresses to a same-day first pass — without changing how we prepare or image our samples.”
Cancer-research lab
FluorocellAI pilot customer · name withheld at customer's request
“It tells us not just what a chemical's current hazard category is, but what it used to be and why it changed. That historical record is exactly what our EHS auditors ask for.”
Dr. S. Okonkwo
Chemical Hygiene Officer, Research University · ComplianceCall pilot customer
See FluorocellAI or ComplianceCall on your own data.
Every demonstration is conducted by the people who build the product, tailored to your workflow — not a generic sales tour.